Digital endpoints and biomarkers hold significant promise for revolutionizing healthcare by providing more precise and continuous monitoring of patient health, potentially transforming drug development and disease management. This workshop will discuss some of the challenges and offer a platform for exploring strategies to accelerate the validation and deployment of digital outcome measures along with case studies. Please refer to the program for a more complete description including the full agenda and references.
Hosted by
- Basel Biometric Society (BBS) and Basel University Department of Neurology.